|
1
|
Coller BS: αIIbβ3: Structure and function.
J Thromb Haemost. 13 (Suppl 1):S17–S25. 2015. View Article : Google Scholar
|
|
2
|
Hynes RO: Integrins: Bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner CL, Mascelli MA, Neblock DS,
Weisman HF, Coller BS and Jordan RE: Analysis of GPIIb/IIIa
receptor number by quantification of 7E3 binding to human
platelets. Blood. 88:907–914. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woods VL Jr, Wolff LE and Keller DM:
Resting platelets contain a substantial centrally located pool of
glycoprotein IIb-IIIa complex which may be accessible to some but
not other extracellular proteins. J Biol Chem. 261:15242–15251.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wencel-Drake JD, Plow EF, Kunicki TJ,
Woods VL, Keller DM and Ginsberg MH: Localization of internal pools
of membrane glycoproteins involved in platelet adhesive responses.
Am J Pathol. 124:324–334. 1986.PubMed/NCBI
|
|
6
|
Cramer EM, Savidge GF, Vainchenker W,
Berndt MC, Pidard D, Caen JP, Massé JM and Breton-Gorius J:
Alpha-granule pool of glycoprotein IIb-IIIa in normal and
pathologic platelets and megakaryocytes. Blood. 75:1220–1227. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ginsberg MH, Du X and Plow EF: Inside-out
integrin signalling. Curr Opin Cell Biol. 4:766–771. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shattil SJ: Signaling through platelet
integrin alpha IIb beta 3: Inside-out, outside-in, and sideways.
Thromb Haemost. 82:318–325. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leclerc JR: Platelet glycoprotein IIb/IIIa
antagonists: Lessons learned from clinical trials and future
directions. Crit Care Med. 30 (Suppl 5):S332–S340. 2002. View Article : Google Scholar
|
|
10
|
Youssefian T, Massé JM, Rendu F, Guichard
J and Cramer EM: Platelet and megakaryocyte dense granules contain
glycoproteins Ib and IIb-IIIa. Blood. 89:4047–4057. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hodivala-Dilke KM, McHugh KP, Tsakiris DA,
Rayburn H, Crowley D, Ullman-Culleré M, Ross FP, Coller BS,
Teitelbaum S and Hynes RO: Beta3-integrin-deficient mice are a
model for Glanzmann thrombasthenia showing placental defects and
reduced survival. J Clin Invest. 103:229–238. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nurden AT: Glanzmann thrombasthenia.
Orphanet J Rare Dis. 1:102006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng X, Novack DV, Faccio R, Ory DS, Aya
K, Boyer MI, McHugh KP, Ross FP and Teitelbaum SL: A Glanzmann's
mutation in beta 3 integrin specifically impairs osteoclast
function. J Clin Invest. 107:1137–1144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi X, Yang J, Cui X, Huang J, Long Z,
Zhou Y, Liu P, Tao L, Ruan Z, Xiao B, et al: Functional effect of
the mutations similar to the cleavage during platelet activation at
integrin β3 cytoplasmic tail when expressed in mouse platelets.
PLoS One. 11:e01661362016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin H, Liu J, Li Z, Berndt MC, Lowell CA
and Du X: Src family tyrosine kinase Lyn mediates
VWF/GPIb-IX-induced platelet activation via the cGMP signaling
pathway. Blood. 112:1139–1146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kikuchi H, Higuchi T, Hashida Y, Taniguchi
A, Kamioka M, Taguchi T, Yokoyama A, Murakami I, Fujieda M and
Daibata M: Generation and characteristics of a novel ‘double-hit’
high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and
BCL6/IGH gene arrangements and potential molecular targeted
therapies. Oncotarget. 9:33482–33499. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fullard JF: The role of the platelet
glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm
Des. 10:1567–1576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coller BS and Shattil SJ: The GPIIb/IIIa
(integrin alphaIIbbeta3) odyssey: A technology-driven saga of a
receptor with twists, turns, and even a bend. Blood. 112:3011–3025.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wilcox DA, Olsen JC, Ishizawa L, Bray PF,
French DL, Steeber DA, Bell WR, Griffith M and White GC II:
Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit
results in the phenotypic correction of Glanzmann thrombasthenia.
Blood. 95:3645–3651. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rosenberg N, Yatuv R, Orion Y, Zivelin A,
Dardik R, Peretz H and Seligsohn U: Glanzmann thrombasthenia caused
by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second
mutation in Iraqi Jews that stemmed from a distinct founder. Blood.
89:3654–3662. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
George JN, Caen JP and Nurden AT:
Glanzmann's thrombasthenia: The spectrum of clinical disease.
Blood. 75:1383–1395. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mesquita R, Santos I and Monteiro H:
Severe intestinal bleeding in a woman with glanzmann
thrombasthenia. Eur J Case Rep Intern Med. 5:0007962018.PubMed/NCBI
|
|
23
|
Fang J, Hodivala-Dilke K, Johnson BD, Du
LM, Hynes RO, White GC II and Wilcox DA: Therapeutic expression of
the platelet-specific integrin, alphaIIbbeta3, in a murine model
for Glanzmann thrombasthenia. Blood. 106:2671–2679. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O'Toole TE, Loftus JC, Plow EF, Glass AA,
Harper JR and Ginsberg MH: Efficient surface expression of platelet
GPIIb-IIIa requires both subunits. Blood. 74:14–18. 1989.
View Article : Google Scholar
|
|
25
|
Offermanns S: Activation of platelet
function through G protein-coupled receptors. Circ Res.
99:1293–1304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ablooglu AJ, Kang J, Petrich BG, Ginsberg
MH and Shattil SJ: Antithrombotic effects of targeting
alphaIIbbeta3 signaling in platelets. Blood. 113:3585–3592. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Petrich BG, Fogelstrand P, Partridge AW,
Yousefi N, Ablooglu AJ, Shattil SJ and Ginsberg MH: The
antithrombotic potential of selective blockade of talin-dependent
integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation. J Clin
Invest. 117:2250–2259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gibbins JM, Okuma M, Farndale R, Barnes M
and Watson SP: Glycoprotein VI is the collagen receptor in
platelets which underlies tyrosine phosphorylation of the Fc
receptor gamma-chain. FEBS Lett. 413:255–259. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Emsley J, Knight CG, Farndale RW, Barnes
MJ and Liddington RC: Structural basis of collagen recognition by
integrin alpha2beta1. Cell. 101:47–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ruggeri ZM: Von Willebrand factor,
platelets and endothelial cell interactions. J Thromb Haemost.
1:1335–1342. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaushansky K, Lichtman MA and Prchal JT:
Williams Hematology. 9th edition. McGraw Hill Education; New York,
NY: pp. 628–639. 2015
|
|
32
|
Kaushansky K, Lichtman MA and Prchal JT:
Williams Hematology. 9th edition. McGraw Hill Education; New York,
NY: pp. 20472015
|
|
33
|
Elmore SA: Enhanced histopathology of the
spleen. Toxicol Pathol. 34:648–655. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rui Z, Ya-Nan H, Jun Y, Wen-Yu W, Bei-Bei
W and Hui-Ming Z: Pathological research of splenic extramedullary
hematopoie sis in aged rats. J Exp Hematol. 26:268–272. 2018.
|
